PubRank

Beatriz Perdiguero

Author PubWeight™ 18.27‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathog 2009 2.24
2 Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates. Proc Natl Acad Sci U S A 2011 1.55
3 MVA and NYVAC as vaccines against emergent infectious diseases and cancer. Curr Gene Ther 2011 1.24
4 Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors. PLoS One 2011 1.16
5 Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02). Vaccine 2011 1.15
6 The HIV/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional, and selective effector memory T cell responses to HIV-1 antigens. J Virol 2011 1.06
7 Improved NYVAC-based vaccine vectors. PLoS One 2011 1.04
8 Improving the MVA vaccine potential by deleting the viral gene coding for the IL-18 binding protein. PLoS One 2012 1.01
9 Poxvirus vectors as HIV/AIDS vaccines in humans. Hum Vaccin Immunother 2012 1.00
10 Removal of vaccinia virus genes that block interferon type I and II pathways improves adaptive and memory responses of the HIV/AIDS vaccine candidate NYVAC-C in mice. J Virol 2012 0.98
11 Cryo X-ray nano-tomography of vaccinia virus infected cells. J Struct Biol 2011 0.98
12 Clinical applications of attenuated MVA poxvirus strain. Expert Rev Vaccines 2013 0.95
13 Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C. PLoS One 2012 0.87
14 High, broad, polyfunctional, and durable T cell immune responses induced in mice by a novel hepatitis C virus (HCV) vaccine candidate (MVA-HCV) based on modified vaccinia virus Ankara expressing the nearly full-length HCV genome. J Virol 2013 0.82
15 A novel HIV vaccine adjuvanted by IC31 induces robust and persistent humoral and cellular immunity. PLoS One 2012 0.80
16 New vaccinia virus promoter as a potential candidate for future vaccines. J Gen Virol 2013 0.80
17 Involvement of the cellular phosphatase DUSP1 in vaccinia virus infection. PLoS Pathog 2013 0.77